Correction: Understanding and Preventing the Global Increase of Inflammatory Bowel Disease (Gastroenterology (2017) 152(2) (313–313.e2) (S0016508516352672) (10.1053/j.gastro.2016.10.020));Understanding and Preventing the Global Increase of Inflammatory Bowel Disease

Gastroenterology

Volumn 152, Issue 2, 2017, Pages 313-321.e2

  Kaplan, Gilaad G ^a,b   Ng, Siew C ^c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Crohn's Disease; Gene Environment Interaction; Microbiota; Ulcerative Colitis

Indexed keywords

ARTICLE; DEVELOPED COUNTRY; DIET; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENETICS; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; MICROBIOME; NONHUMAN; ORGANIZATION; PATHOGENESIS; PRIORITY JOURNAL; RISK; DYSBIOSIS; ENVIRONMENT; GENETIC PREDISPOSITION; GENOTYPE ENVIRONMENT INTERACTION; GLOBAL HEALTH; INDUSTRIALIZATION; INFLAMMATORY BOWEL DISEASES; INTESTINE FLORA; PREVALENCE; WESTERN DIET;

DEVELOPED COUNTRIES; DIET, WESTERN; DYSBIOSIS; ENVIRONMENT; GASTROINTESTINAL MICROBIOME; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GLOBAL HEALTH; HUMANS; INCIDENCE; INDUSTRIAL DEVELOPMENT; INFLAMMATORY BOWEL DISEASES; PREVALENCE;

EID: 85007478309     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2017.05.018     Document Type: Erratum

References (107)

1. 1 Kaplan, G.G., The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol 12 (2015), 720–727.
2. 2 Wilks, S., Moxon, W., Lectures on pathological anatomy. 2nd ed., 1875, J & A Churchill, London.
3. 3 Mulder, D.J., Noble, A.J., Justinich, C.J., et al. A tale of two diseases: the history of inflammatory bowel disease. J Crohns Colitis 8 (2014), 341–348.
4. 4 Crafts, N., Productivity growth in the industrial revolution: a new growth accounting perspective. J Econ Hist 64 (2004), 521–535.
5. 5 Crohn, B.B., Ginzburg, L., Oppenheimer, G.D., Regional ileitis: a pathologic and clinical entity. JAMA 99 (1932), 1323–1329.
6. 6 Waters, C.N., Zalasiewicz, J., Summerhayes, C., et al. The Anthropocene is functionally and stratigraphically distinct from the Holocene. Science, 351, 2016, aad2622.
7. 7 Molodecky, N.A., Panaccione, R., Ghosh, S., et al. Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases. Inflamm Bowel Dis 17 (2011), 1792–1799.
8. 8 Zwi, A.B., Mills, A., Health policy in less developed countries: past trends and future directions. J Int Dev 7 (1995), 299–328.
9. 9 Jiang, X.-L., Cui, H.-F., An analysis of 10218 ulcerative colitis cases in China. World J Gastroenterol 8 (2002), 158–161.
10. 10 Molodecky, N.A., Soon, I.S., Rabi, D.M., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142 (2012), 46–54.e42 quiz e30.
11. 11 Benchimol, E.I., Manuel, D.G., Guttmann, A., et al. Changing age demographics of inflammatory bowel disease in Ontario, Canada: a population-based cohort study of epidemiology trends. Inflamm Bowel Dis 20 (2014), 1761–1769.
12. 12 Kappelman, M.D., Moore, K.R., Allen, J.K., et al. Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci 58 (2013), 519–525.
13. 13 Busch, K., Ludvigsson, J.F., Ekstrom-Smedby, K., et al. Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study. Aliment Pharmacol Ther 39 (2014), 57–68.
14. 14 Stone, M.A., Mayberry, J.F., Baker, R., Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England. Eur J Gastroenterol Hepatol 15 (2003), 1275–1280.
15. 15 Hein, R., Koster, I., Bollschweiler, E., et al. Prevalence of inflammatory bowel disease: estimates for 2010 and trends in Germany from a large insurance-based regional cohort. Scand J Gastroenterol 49 (2014), 1325–1335.
16. 16 Lucendo, A.J., Hervias, D., Roncero, O., et al. Epidemiology and temporal trends (2000-2012) of inflammatory bowel disease in adult patients in a central region of Spain. Eur J Gastroenterol Hepatol 26 (2014), 1399–1407.
17. 17 Gearry, R.B., Richardson, A., Frampton, C.M.A., et al. High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study. Inflamm Bowel Dis 12 (2006), 936–943.
18. 18 Burisch, J., Jess, T., Martinato, M., et al. The burden of inflammatory bowel disease in Europe. J Crohns Colitis 7 (2013), 322–337.
19. 19 Kappelman, M.D., Rifas-Shiman, S.L., Kleinman, K., et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 5 (2007), 1424–1429.
20. 20 Benchimol, E.I., Guttmann, A., Griffiths, A.M., et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut 58 (2009), 1490–1497.
21. 21 Bitton, A., Vutcovici, M., Patenaude, V., et al. Epidemiology of inflammatory bowel disease in Quebec: recent trends. Inflamm Bowel Dis 20 (2014), 1770–1776.
22. 22 Leddin, D., Tamim, H., Levy, A.R., Decreasing incidence of inflammatory bowel disease in Eastern Canada: a population database study. BMC Gastroenterol, 14, 2014, 140.
23. 23 Sedlack, R.E., Nobrega, F.T., Kurland, L.T., et al. Inflammatory colon disease in Rochester, Minnesota, 1935-1964. Gastroenterology 62 (1972), 935–941.
24. 24 Sedlack, R.E., Whisnant, J., Elveback, L.R., et al. Incidence of Crohn's disease in Olmsted County, Minnesota, 1935-1975. Am J Epidemiol 112 (1980), 759–763.
25. 25 Loftus, E.V. Jr., Silverstein, M.D., Sandborn, W.J., et al. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 114 (1998), 1161–1168.
26. 26 Loftus, C.G., Loftus, E.V. Jr., Harmsen, W.S., et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 13 (2007), 254–261.
27. 27 Shivashankar, R., Tremaine, W., Harmsen, S., et al. Updated incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota (1970-2010). Am J Gastroenterol, 109(Suppl 2), 2014, S499.
28. 28 Coward, S., Clement, F., Williamson, T., et al. The rising burden of inflammatory bowel disease in North America from 2015 to 2025: a predictive model. Am J Gastroenterol, 110, 2015, S835.
29. 29 Asakura, K., Nishiwaki, Y., Inoue, N., et al. Prevalence of ulcerative colitis and Crohn's disease in Japan. J Gastroenterol 44 (2009), 659–665.
30. 30 Yang, S.-K., Yun, S., Kim, J.-H., et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis 14 (2008), 542–549.
31. 31 Niu, J., Miao, J., Tang, Y., et al. Identification of environmental factors associated with inflammatory bowel disease in a southwestern highland region of China: a nested case-control study. PLoS One, 11, 2016, e0153524.
32. 32 Ng, S.C., Tang, W., Ching, J.Y., et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology 145 (2013), 158–165.e152.
33. 33 Ng, S., Kaplan, G.G., Banerjee, R., et al. Incidence and phenotype of inflammatory bowel disease from 13 countries in Asia-pacific: results from the Asia-Pacific Crohn's and colitis epidemiologic study 2011-2013. Gastroenterology, 150(Suppl 1), 2016, S21.
34. 34 Ng, S.C., Bernstein, C.N., Vatn, M.H., et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut 62 (2013), 630–649.
35. 35 Parente, J.M., Coy, C.S., Campelo, V., et al. Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil. World J Gastroenterol 21 (2015), 1197–1206.
36. 36 Victoria, C.R., Sassak, L.Y., Nunes, H.R., Incidence and prevalence rates of inflammatory bowel diseases, in midwestern of Sao Paulo State, Brazil. Arq Gastroenterol 46 (2009), 20–25.
37. 37 Buenavida, G., Casanas, A., Vasquez, C., et al. Incidence of inflammatory bowel disease in five geographical areas of Uruguay in the biennial 2007-2008. Acta Gastroenterol Latinoam 41 (2011), 281–287.
38. 38 Edwards, C.N., Griffith, S.G., Hennis, A.J., et al. Inflammatory bowel disease: incidence, prevalence, and disease characteristics in Barbados, West Indies. Inflamm Bowel Dis 14 (2008), 1419–1424.
39. 39 Roth, M.P., Petersen, G.M., McElree, C., et al. Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology 96 (1989), 1016–1020.
40. 40 Brant, S.R., Update on the heritability of inflammatory bowel disease: the importance of twin studies. Inflamm Bowel Dis 17 (2011), 1–5.
41. 41 Halfvarson, J., Jess, T., Magnuson, A., et al. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis 12 (2006), 925–933.
42. 42 Hampe, J., Cuthbert, A., Croucher, P.J., et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357 (2001), 1925–1928.
43. 43 Hugot, J.P., Chamaillard, M., Zouali, H., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001), 599–603.
44. 44 Ogura, Y., Bonen, D.K., Inohara, N., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001), 603–606.
45. 45 Jostins, L., Ripke, S., Weersma, R.K., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491 (2012), 119–124.
46. 46 Khor, B., Gardet, A., Xavier, R.J., Genetics and pathogenesis of inflammatory bowel disease. Nature 474 (2011), 307–317.
47. 47 Liu, J.Z., van Sommeren, S., Huang, H., et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 47 (2015), 979–986.
48. 48 Zhernakova, A., van Diemen, C.C., Wijmenga, C., Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 10 (2009), 43–55.
49. 49 Huang, C., Haritunians, T., Okou, D.T., et al. Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans. Gastroenterology 149 (2015), 1575–1586.
50. 50 Ventham, N.T., Kennedy, N.A., Nimmo, E.R., et al. Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. Gastroenterology 145 (2013), 293–308.
51. 51 Ng, S.C., Leong, R.W., Ko, Y., et al. Environmental risk factors in inflammatory bowel disease in Asia-Pacific: a population-based case-control study. Gastroenterology 1 (2014), S771–S772.
52. 52 Ananthakrishnan, A.N., Environmental risk factors for inflammatory bowel diseases: a review. Dig Dis Sci 60 (2015), 290–298.
53. 53 Calkins, B.M., A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 34 (1989), 1841–1854.
54. 54 Shaw, S.Y., Blanchard, J.F., Bernstein, C.N., Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis. Am J Gastroenterol 106 (2011), 2133–2142.
55. 55 Barclay, A.R., Russell, R.K., Wilson, M.L., et al. Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease. J Pediatr 155 (2009), 421–426.
56. 56 Boyko, E.J., Theis, M.K., Vaughan, T.L., et al. Increased risk of inflammatory bowel disease associated with oral contraceptive use. Am J Epidemiol 140 (1994), 268–278.
57. 57 Andersson, R.E., Olaison, G., Tysk, C., et al. Appendectomy and protection against ulcerative colitis. N Engl J Med 344 (2001), 808–814.
58. 58 Ananthakrishnan, A.N., Khalili, H., Higuchi, L.M., et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 142 (2012), 482–489.
59. 59 Ng, S.C., Tang, W., Leong, R.W., et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut 64 (2015), 1063–1071.
60. 60 Strachan, D.P., Hay fever, hygiene, and household size. BMJ 299 (1989), 1259–1260.
61. 61 Bernstein, C.N., Wajda, A., Svenson, L.W., et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 101 (2006), 1559–1568.
62. 62 Frolkis, A., Dieleman, L.A., Barkema, H.W., et al. Environment and the inflammatory bowel diseases. Can J Gastroenterol 27 (2013), e18–e24.
63. 63 Probert, C.S., Jayanthi, V., Pinder, D., et al. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 33 (1992), 687–693.
64. 64 Sood, A., Amre, D., Midha, V., et al. Low hygiene and exposure to infections may be associated with increased risk for ulcerative colitis in a North Indian population. Ann Gastroenterol 27 (2014), 219–223.
65. 65 Leong, R.W., Mitrev, N., Ko, Y., Hygiene hypothesis: is the evidence the same all over the world?. Dig Dis 34 (2016), 35–42.
66. 66 Sands, B.E., Within you, without you: is gastroenterology ready to embrace the “exposome”?. Gastroenterology 142 (2012), 1403–1404.
67. 67 Li, L.M., Rao, K.Q., Kong, L.Z., et al. [A description on the Chinese national nutrition and health survey in 2002]. Zhonghua Liu Xing Bing Xue Za Zhi 26 (2005), 478–484.
68. 68 Wang, H., Wang, N., Wang, B., et al. Antibiotics detected in urines and adipogenesis in school children. Environ Int 89–90 (2016), 204–211.
69. 69 Ananthakrishnan, A.N., Khalili, H., Konijeti, G.G., et al. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology 145 (2013), 970–977.
70. 70 Geerling, B.J., Dagnelie, P.C., Badart-Smook, A., et al. Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol 95 (2000), 1008–1013.
71. 71 IBD in EPIC Study Investigators, Tjonneland, A., Overvad, K., et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut 58 (2009), 1606–1611.
72. 72 Jantchou, P., Morois, S., Clavel-Chapelon, F., et al. Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am J Gastroenterol 105 (2010), 2195–2201.
73. 73 Reif, S., Klein, I., Lubin, F., et al. Pre-illness dietary factors in inflammatory bowel disease. Gut 40 (1997), 754–760.
74. 74 Persson, P.G., Ahlbom, A., Hellers, G., Diet and inflammatory bowel disease: a case-control study. Epidemiology 3 (1992), 47–52.
75. 75 Chaumard, N., Limat, S., Villanueva, C., et al. Incidence and risk factors of anemia in patients with early breast cancer treated by adjuvant chemotherapy. Breast 21 (2012), 464–467.
76. 76 Perrin, A.E., Dallongeville, J., Ducimetiere, P., et al. Interactions between traditional regional determinants and socio-economic status on dietary patterns in a sample of French men. Br J Nutr 93 (2005), 109–114.
77. 77 Suez, J., Korem, T., Zeevi, D., et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514 (2014), 181–186.
78. 78 Chassaing, B., Koren, O., Goodrich, J.K., et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 519 (2015), 92–96.
79. 79 Burisch, J., Pedersen, N., Cukovic-Cavka, S., et al. Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe–an ECCO-EpiCom study. J Crohns Colitis 8 (2014), 607–616.
80. 80 Sakamato, N., Kono, S., Wakai, K., et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis 11 (2005), 154–163.
81. 81 De Cruz, P., Prideaux, L., Wagner, J., et al. Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease. Inflamm Bowel Dis 18 (2012), 372–390.
82. 82 Prideaux, L., Kang, S., Wagner, J., et al. Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease. Inflamm Bowel Dis 19 (2013), 2906–2918.
83. 83 Kostic, A.D., Xavier, R.J., Gevers, D., The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146 (2014), 1489–1499.
84. 84 Gevers, D., Kugathasan, S., Denson, L.A., et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15 (2014), 382–392.
85. 85 De Cruz, P., Kang, S., Wagner, J., et al. Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: a pilot study. J Gastroenterol Hepatol 30 (2015), 268–278.
86. 86 He, Y., Xu, P., Zeng, Z., et al. The prevalence and clinical characteristics of refractory Crohn's disease in South China. J Crohns Colitis 8 (2014), S197–S198.
87. 87 Wright, E.K., Kamm, M.A., Wagner, J., What causes recurrence of Crohn's disease after intestinal resection? A prospective evaluation of microbiota, smoking and anti-TNF therapy. Results from the POCER study. Gastroenterology, 148, 2015, S-60.
88. 88 Darfeuille-Michaud, A., Boudeau, J., Bulois, P., et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127 (2004), 412–421.
89. 89 Lopes, F., Matisz, C., Reyes, J.L., et al. Helminth regulation of immunity: a three-pronged approach to treat colitis. Inflamm Bowel Dis 22 (2016), 2499–2512.
90. 90 Sandborn, W.J., Elliot, D.E., Weinstock, J., et al. Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's disease. Aliment Pharmacol Ther 38 (2013), 255–263.
91. 91 Feller, M., Huwiler, K., Stephan, R., et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis 7 (2007), 607–613.
92. 92 Le Chatelier, E., Nielsen, T., Qin, J., et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500 (2013), 541–546.
93. 93 Yatsunenko, T., Rey, F.E., Manary, M.J., et al. Human gut microbiome viewed across age and geography. Nature 486 (2012), 222–227.
94. 94 Gensollen, T., Iyer, S.S., Kasper, D.L., et al. How colonization by microbiota in early life shapes the immune system. Science 352 (2016), 539–544.
95. 95 Blaser, M.J., Antibiotic use and its consequences for the normal microbiome. Science 352 (2016), 544–545.
96. 96 Sonnenburg, E.D., Smits, S.A., Tikhonov, M., et al. Diet-induced extinctions in the gut microbiota compound over generations. Nature 529 (2016), 212–215.
97. 97 Korpela, K., Salonen, A., Virta, L.J., et al. Association of early-life antibiotic use and protective effects of breastfeeding: role of the intestinal microbiota. JAMA Pediatr 170 (2016), 750–757.
98. 98 Wu, G.D., Chen, J., Hoffmann, C., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (2011), 105–108.
99. 99 Zhernakova, A., Kurilshikov, A., Bonder, M.J., et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352 (2016), 565–569.
100. 100 Roberts, C.L., Keita, A.V., Duncan, S.H., et al. Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers. Gut 59 (2010), 1331–1339.
101. 101 Galvez, J., Rodriguez-Cabezas, M.E., Zarzuelo, A., Effects of dietary fiber on inflammatory bowel disease. Mol Nutr Food Res 49 (2005), 601–608.
102. 102 Long, M.D., Hutfless, S., Kappelman, M.D., et al. Challenges in designing a national surveillance program for inflammatory bowel disease in the United States. Inflamm Bowel Dis 20 (2014), 398–415.
103. 103 Klement, E., Cohen, R.V., Boxman, J., et al. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr 80 (2004), 1342–1352.
104. 104 Kaplan, G.G., Does consuming the recommend daily level of fiber prevent Crohn's disease?. Gastroenterology 145 (2013), 925–927.
105. 105 Natural Earth Development Team. Cultural vectors: countries. North American Cartographic Information Society. Available from: http://www.naturalearthdata.com. Accessed: June 16, 2016.
106. 106 QGIS Development Team. QGIS geographic information system. Open Source Geospatial Foundation Project. Available from: http://www.qgis.org/. Accessed: June 16, 2016.
107. 107 Duivenvoorde R. HTML image map plugin for QGIS. Open Source Geospatial Foundation Project. Available from: http://hub.qgis.org/projects/imagemapplugin. Accessed: June 16, 2016.